44 منٹ پہلے
NextDC posts FY2026 revenue of A$496.5 million and guides FY2027 underlying EBITDA to A$385 million–A$410 million
NextDC reported FY2026 revenue of A$496.5 million, up 16% year on year, and underlying EBITDA of A$248.8 million, up 15%. The company forecast FY2027 underlying EBITDA of A$385 million to A$410 million. Cleanaway Waste Management received a conditional, nonbinding indicative takeover proposal from EQT Infrastructure at A$3.13 a share in cash, valuing the deal at about A$9.4 billion. New Hope Corporation shares slipped slightly on the day.
44 منٹ پہلے
57 منٹ پہلے
Blaize sees preliminary Q3 2026 revenue of about $0.5 million, cuts full-year outlook to $32.0 million-$36.0 million
Blaize said it expects preliminary third-quarter 2026 revenue of about $0.5 million for the period ended September 30, 2026. The company lowered its full-year 2026 revenue guidance to a range of $32.0 million to $36.0 million. It said the updated outlook is based on binding, noncancellable purchase orders from NeoTensr and a new purchase order from an existing customer that is in the process of being signed. Blaize added that shipments to NeoTensr during the quarter relate to the contract it announced in April 2026 for up to $50.0 million.
57 منٹ پہلے
2 گھنٹے پہلے
Strategy adds 334 BTC, lifting holdings to a record 848,000 as MSTR tests $164-$164.80
Strategy said on Oct. 5 it purchased 334 BTC, taking its total Bitcoin holdings to a record 848,000 BTC. The company also estimated a $20.91 billion unrealized gain on its digital assets in the third quarter. MSTR shares rose 2.44% to $163.91, testing resistance in the $164 to $164.80 range, with $163 seen as nearby support. Strategy also reported repurchasing about $176.3 million of STRC preferred stock across two reporting periods.
BTC
BTC-1.09%
2 گھنٹے پہلے
2 گھنٹے پہلے
CSL signs Alentis deal for claudin1 drug, shares trade near A$177
CSL Limited said it has struck a drug-development partnership with Alentis focused on an investigational claudin1-targeting therapy now in a Phase 2 trial for a rare autoimmune kidney disease. CSL will pay US$355 million upfront and fund the planned development program, while the companies would split global profits 55% to CSL and 45% to Alentis if the treatment reaches the market. CSL shares were trading around A$177 on Tuesday, implying a price-to-earnings multiple of just under 20 times FY27 consensus earnings per share of A$8.99, falling to about 17.5 times based on FY29 EPS of A$10.08.
2 گھنٹے پہلے
3 گھنٹے پہلے
Trump Says the Strait of Hormuz No Longer Drives U.S. Gas Prices After Tanker Hit
A projectile struck a tanker in the Strait of Hormuz on Monday, sparking a fire in its engine room. The crew was working to extinguish the blaze, according to the UK Maritime Trade Operations office. The agency said the report was its 10th incident notice since October 1. U.S. President Donald Trump said the strait is no longer a factor behind higher gasoline prices for Americans.
3 گھنٹے پہلے
5 گھنٹے پہلے
Unite warns strikes by 160+ Apache North Sea workers could halt Forties pipeline system
Unite has warned that strike action by more than 160 Apache workers in the North Sea could shut down the Forties Pipeline System. The pipeline, operated by Ineos, carries 29% of the UK’s oil and 30% of its gas, and the union said stoppages could severely disrupt fuel supplies. Apache’s parent, APA Corporation, reported after-tax profits of £1.2 billion in 2025.
5 گھنٹے پہلے